Jump directly to
Jump directly to the main content
Jump directly to the search
Carl Zeiss Meditec Group – Annual Report
2024/25
de
en
Fiscal year
Fiscal year
Key performance indicators
Letter to the shareholders
ZEISS Expert Talk 2025
The Supervisory Board
Report of the Supervisory Board
Share
Summary management report
Summary management report
Carl Zeiss Meditec Group
Business report
Business report
Underlying conditions
Overall assertion on the financial position
Results of operations
Financial position
Net assets
Orders on hand
Events of particular significance
Non-financial performance indicators
Non-financial performance indicators
Sustainability
Employees
Compliance
Production
Research and development
Brands and patents
Financial statements of Carl Zeiss Meditec AG
Financial statements of Carl Zeiss Meditec AG
Preparation of the financial statements
Summary of business development
Income statement according to HGB
Results of operations
Balance sheet
Net assets and financial position
Employees
Appropriation of profits
Declaration on corporate governance and corporate governance report
Opportunity and risk report
Opportunity and risk report
Risk management
Major opportunities
Significant risks
Disclosures pursuant to Section 289a and 315a HGB
Outlook
Final declaration of the Management Board on the dependent company report
Declaration on corporate governance and corporate governance report
Remuneration report
Remuneration report
Remuneration of the Management Board
Remuneration of the Supervisory Board
Auditor’s Report
Consolidated financial statements
Consolidated financial statements
Consolidated income statement
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of changes in equity
Consolidated statement of cash flows
Notes
Notes
General principles, accounting and valuation principles
General principles, accounting and valuation principles
1
General principles
2
Accounting and valuation policies
3
Reporting entity
4
Summarized financial information of material subsidiaries with non-controlling interests
Notes to the consolidated income statement
Notes to the consolidated income statement
5
Revenue
6
Other operating result
7
Personnel expenses
8
Financial result
9
Income taxes
10
Earnings per share
Notes to the consolidated statement of financial position
Notes to the consolidated statement of financial position
11
Goodwill
12
Other intangible assets
13
Property, plant and equipment
14
At-equity investments
15
Inventories
16
Other financial assets
17
Other non-financial assets
18
Cash and cash equivalents
19
Assets held for sale
20
Equity
21
Provisions for pensions and similar obligations
22
Other provisions
23
Financial liabilities
24
Accrued liabilities
25
Other non-financial liabilities
26
Financial instruments and risk management
Other disclosures
Other disclosures
27
Notes to the statement of cash flows
28
Leases
29
Segment reporting
30
Government grants
31
Related party disclosures
32
Notifiable transactions in the reporting period
33
Additional disclosures on capital management
34
Events after the end of the reporting period
35
Other mandatory disclosures pursuant to Section 315e HGB
36
Clearance for publication
Responsibility statement
Independent Auditor’s Report
Open search
Open main navigation
Close main navigation
Main menu
Fiscal year
Fiscal year
Key performance indicators
Letter to the shareholders
ZEISS Expert Talk 2025
The Supervisory Board
Report of the Supervisory Board
Share
Summary management report
Summary management report
Carl Zeiss Meditec Group
Business report
Business report
Underlying conditions
Overall assertion on the financial position
Results of operations
Financial position
Net assets
Orders on hand
Events of particular significance
Non-financial performance indicators
Non-financial performance indicators
Sustainability
Employees
Compliance
Production
Research and development
Brands and patents
Financial statements of Carl Zeiss Meditec AG
Financial statements of Carl Zeiss Meditec AG
Preparation of the financial statements
Summary of business development
Income statement according to HGB
Results of operations
Balance sheet
Net assets and financial position
Employees
Appropriation of profits
Declaration on corporate governance and corporate governance report
Opportunity and risk report
Opportunity and risk report
Risk management
Major opportunities
Significant risks
Disclosures pursuant to Section 289a and 315a HGB
Outlook
Final declaration of the Management Board on the dependent company report
Declaration on corporate governance and corporate governance report
Remuneration report
Remuneration report
Remuneration of the Management Board
Remuneration of the Supervisory Board
Auditor’s Report
Consolidated financial statements
Consolidated financial statements
Consolidated income statement
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of changes in equity
Consolidated statement of cash flows
Notes
Notes
General principles, accounting and valuation principles
General principles, accounting and valuation principles
1
General principles
2
Accounting and valuation policies
3
Reporting entity
4
Summarized financial information of material subsidiaries with non-controlling interests
Notes to the consolidated income statement
Notes to the consolidated income statement
5
Revenue
6
Other operating result
7
Personnel expenses
8
Financial result
9
Income taxes
10
Earnings per share
Notes to the consolidated statement of financial position
Notes to the consolidated statement of financial position
11
Goodwill
12
Other intangible assets
13
Property, plant and equipment
14
At-equity investments
15
Inventories
16
Other financial assets
17
Other non-financial assets
18
Cash and cash equivalents
19
Assets held for sale
20
Equity
21
Provisions for pensions and similar obligations
22
Other provisions
23
Financial liabilities
24
Accrued liabilities
25
Other non-financial liabilities
26
Financial instruments and risk management
Other disclosures
Other disclosures
27
Notes to the statement of cash flows
28
Leases
29
Segment reporting
30
Government grants
31
Related party disclosures
32
Notifiable transactions in the reporting period
33
Additional disclosures on capital management
34
Events after the end of the reporting period
35
Other mandatory disclosures pursuant to Section 315e HGB
36
Clearance for publication
Responsibility statement
Independent Auditor’s Report
Downloads
Related ZEISS Websites
Carl Zeiss Meditec AG
ZEISS Group
Downloads
Search
Share
E-mail
E-mail
LinkedIn
X
Facebook
Back to top
